Compare, Analyse Dr. Reddys with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ACTAVIS (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ACTAVIS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
ACTAVIS
Dec-18
DR. REDDYS LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,36314,106-   
Low Rs2,3529,462-   
Sales per share (Unadj.) Rs1,054.23,460.2-  
Earnings per share (Unadj.) Rs121.9-1,114.5-  
Cash flow per share (Unadj.) Rs190.2364.6-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs938.714,271.8-  
Shares outstanding (eoy) m166.17332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.73.4 79.6%   
Avg P/E ratio x23.4-10.6 -221.7%  
P/CF ratio (eoy) x15.032.3 46.5%  
Price / Book Value ratio x3.00.8 368.7%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m474,8313,919,453 12.1%   
No. of employees `00021.716.9 128.1%   
Total wages/salary Rs m33,8020-   
Avg. sales/employee Rs Th8,091.068,099.0 11.9%   
Avg. wages/employee Rs Th1,561.30-   
Avg. net profit/employee Rs Th935.8-21,934.7 -4.3%   
INCOME DATA
Net Sales Rs m175,1701,150,872 15.2%  
Other income Rs m6,20622,009 28.2%   
Total revenues Rs m181,3761,172,881 15.5%   
Gross profit Rs m24,42130,159 81.0%  
Depreciation Rs m11,348491,973 2.3%   
Interest Rs m98366,412 1.5%   
Profit before tax Rs m18,296-506,218 -3.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m0129,106 0.0%   
Tax Rs m-1,403-6,415 21.9%   
Profit after tax Rs m20,260-370,697 -5.5%  
Gross profit margin %13.92.6 532.0%  
Effective tax rate %-7.71.3 -605.1%   
Net profit margin %11.6-32.2 -35.9%  
BALANCE SHEET DATA
Current assets Rs m125,991472,028 26.7%   
Current liabilities Rs m72,141417,571 17.3%   
Net working cap to sales %30.74.7 649.7%  
Current ratio x1.71.1 154.5%  
Inventory Days Days7320 373.1%  
Debtors Days Days10566 158.0%  
Net fixed assets Rs m83,854130,272 64.4%   
Share capital Rs m8310-   
"Free" reserves Rs m155,1570-   
Net worth Rs m155,9884,746,811 3.3%   
Long term debt Rs m1,3041,671,524 0.1%   
Total assets Rs m232,2537,420,345 3.1%  
Interest coverage x19.6-6.6 -296.2%   
Debt to equity ratio x00.4 2.4%  
Sales to assets ratio x0.80.2 486.3%   
Return on assets %9.1-4.1 -223.0%  
Return on equity %13.0-7.8 -166.3%  
Return on capital %12.6-4.8 -260.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m44,5770-   
CASH FLOW
From Operations Rs m29,841411,163 7.3%  
From Investments Rs m-4,923225,881 -2.2%  
From Financial Activity Rs m-25,159-705,679 3.6%  
Net Cashflow Rs m-266-68,293 0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.9 Rs / USD

Compare DR. REDDYS LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: NOVARTIS  IPCA LABS  DIVIS LABORATORIES  LUPIN  SHASUN PHARMA  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views On News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Mar 5, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - JUBILANT PHARMOVA COMPARISON

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

A Time Correction in the Nifty

The Best Stocks in a Volatile Market

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

More Featured Videos

MARKET STATS